122 related articles for article (PubMed ID: 3244707)
1. Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation.
Boja JW; Schechter MD
Pharmacol Biochem Behav; 1988 Oct; 31(2):305-11. PubMed ID: 3244707
[TBL] [Abstract][Full Text] [Related]
2. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
Schechter MD
Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anorectic drugs in rats trained to discriminate between satiation and deprivation.
Schechter MD
Life Sci; 1990; 47(1):17-24. PubMed ID: 2388514
[TBL] [Abstract][Full Text] [Related]
4. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
Clausing P; Newport GD; Bowyer JF
J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.
McElroy JF; Feldman RS
Psychopharmacology (Berl); 1984; 83(2):172-8. PubMed ID: 6431469
[TBL] [Abstract][Full Text] [Related]
6. Fenfluramine discrimination in obese and lean Zucker rats: serotonergic mediation of effect.
Schechter MD
Eur J Pharmacol; 1986 Jun; 125(1):135-41. PubMed ID: 3732388
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic mediation of tetrahydro-beta-carboline.
Schechter MD
Pharmacol Biochem Behav; 1986 May; 24(5):1209-13. PubMed ID: 3725827
[TBL] [Abstract][Full Text] [Related]
8. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
Borroni E; Ceci A; Garattini S; Mennini T
J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
[TBL] [Abstract][Full Text] [Related]
9. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
[TBL] [Abstract][Full Text] [Related]
10. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
Invernizzi R; Kmieciak-Kolada K; Samanin R
Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
[TBL] [Abstract][Full Text] [Related]
11. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
Vickers SP; Dourish CT; Kennett GA
Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
[TBL] [Abstract][Full Text] [Related]
12. Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation.
Schechter MD
Pharmacol Biochem Behav; 1988 Sep; 31(1):53-7. PubMed ID: 3252260
[TBL] [Abstract][Full Text] [Related]
13. Effect of (+)- or (-)-enantiomers of fenfluramine or norfenfluramine on nutrient selection by rats.
Hirsch JA; Goldberg S; Wurtman RJ
J Pharm Pharmacol; 1982 Jan; 34(1):18-21. PubMed ID: 6121026
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Schechter MD
Pharmacol Biochem Behav; 1988 Dec; 31(4):817-24. PubMed ID: 2908067
[TBL] [Abstract][Full Text] [Related]
16. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
[TBL] [Abstract][Full Text] [Related]
17. Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.
Cozzi NV; Frescas S; Marona-Lewicka D; Huang X; Nichols DE
Pharmacol Biochem Behav; 1998 Mar; 59(3):709-15. PubMed ID: 9512076
[TBL] [Abstract][Full Text] [Related]
18. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
Johnson MP; Nichols DE
Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
[TBL] [Abstract][Full Text] [Related]
19. TFMPP may produce its stimulus effects via a 5-HT1B mechanism.
McKenney JD; Glennon RA
Pharmacol Biochem Behav; 1986 Jan; 24(1):43-7. PubMed ID: 3945665
[TBL] [Abstract][Full Text] [Related]
20. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
Callaway CW; Wing LL; Nichols DE; Geyer MA
Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
